Navigation Links
Biosensors Reports Financial Results for the Third Quarter of Fiscal Year 2013
Date:2/7/2013

t, including regulatory imposition and new products from competitors, licensing revenue from Terumo Corporation (Terumo) for the sales of the Nobori DES was adversely affected in the first nine months of the fiscal year. As such, management is adjusting its guidance for total revenue for the fiscal year ending 31 March 2013 (FY13) to a 15% to 20% growth over FY12, driven by continued strong DES revenue growth in the key markets managed by the Company, but offset by a decrease in licensing revenue.

"We will leverage our experience in the international markets, along with the positive clinical results we achieved, to work closely with Terumo to strengthen Nobori's competitive position in Japan, aiming at increasing the product's market share and our royalty revenue. In China, we have seen that the tendering process has accelerated, which will inevitably create some short-term disruptions. However, this will remove the overhanging uncertainty on the future of this important market. At the same time, we will also introduce new products to improve our overall sales revenue in China. For the rest of the world, we continued to perform well in Europe and Asia Pacific, with strong year-on-year growth outpacing the market," said Dr. Wang. "During the quarter, we successfully raised approximately US$240 million from the bond offering. Coupled with our existing financial resources, we accumulated more than US$570 million of cash and cash equivalents. We are in various stages of discussions with several potential M&A targets, some of these discussions being near completion. We believe these possible transactions, once concluded, can further expand our product offering. Such efforts can substantially increase our shareholder value and take Biosensors to the next level."

About Biosensors International Group, Ltd

Biosensors Inter
'/>"/>

SOURCE Biosensors International Group, Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Biosensors Reports Strong Sales and Profitability in the First Quarter of Fiscal Year 2013
2. Sigma-Aldrich Reports Record Full Year 2012 Results. Reports Q4 2012 Diluted EPS Of $0.96. Q4 2012 Sales Increased 7%. Full Year 2012 Adjusted Diluted EPS Was $3.85. Expects Full Year 2013 Adjusted Diluted EPS To Increase To $4.10 - $4.20.
3. Cambrex Reports Fourth Quarter And Full Year 2012 Financial Results
4. Sangamo BioSciences Reports Fourth Quarter And Full Year 2012 Financial Results
5. Plaintiff in Prolift Vaginal Mesh Case Testifies She Can No Longer Work, Have Sex, or Function Normally, Rottenstein Law Group Reports
6. Mesa Labs Reports 18% Increase in Third Quarter Revenues
7. Cardinal Health Reports Fiscal 2013 Second-Quarter Results
8. Luminex Corporation Reports Fourth Quarter And Full Year 2012 Results
9. InspireMD Reports Results for Period Ended Dec. 31, 2012
10. BRICS NPWT Market and Pressure Relief Devices Industry Analysis in New Research Reports at ReportsnReports.com
11. Trimedyne Reports Financial Results For The Quarter And Fiscal Year Ended September 30, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 29, 2015  The annual customer satisfaction survey of ... EMR as #1 across all specialties. Every year, ... conducts a poll of EHR users and publishes an ... Praxis EMR topped 348 other systems, ... based criteria used by Black Book. In addition to ...
(Date:5/29/2015)... 2015 /CNW/ - Covalon Technologies Ltd. (the "Company" or ... is delighted to announce its financial results for ... includes revenue for three months of $2,180,276 and ... advanced wound care product sales for the three ... to $1,742,672 compared to $1,400,065 for the same ...
(Date:5/29/2015)... 2015 Amgen (NASDAQ: AMGN ) ... 3, global, randomized, placebo-controlled trials evaluating AMG 416, ... hyperparathyroidism (SHPT) in patients with chronic kidney disease ... endpoint, demonstrating that a greater proportion of patients ... than 30 percent reduction in parathyroid hormone (PTH) ...
Breaking Medicine Technology:Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7
(Date:5/29/2015)... Abington Hospital – Jefferson Health ... hospitals in the nation to join the ... and work toward achieving the Baby-Friendly USA© designation. ... on maternity care practices leading to Baby-Friendly designation. ... Prevention, EMPower is aimed at increasing breastfeeding rates ...
(Date:5/29/2015)... On May 21, 2015, Elle Magazine in article titled ... Botox ?” reported on the four most commonly searched beauty ... to determine these results and then sought expert help to ... example, is how to keep neck skin tight . ... the appropriate age to start receiving Botox injections . ...
(Date:5/29/2015)... The Healthcare Delivery Institute at HORNE ... Training Program (ATP) in Healthcare Delivery Improvement. The ... health care organization ranging from clinicians to CFOs, ... quality improvement in the health care environment. The ... internationally recognized Advanced Training Program at Intermountain Healthcare. ...
(Date:5/29/2015)... 29, 2015 The print component of ... circulation of approximately 250,000 and an estimated readership of ... vast social media strategy, and across a network of ... digital version of the campaign, click here. ... publication. Inside, the actress, model and producer details her ...
(Date:5/29/2015)... Shaila Jiwa, a physiotherapist from Burnaby ... stated in a new announcement that patients of urinary ... commonly seen as a tabooed topic to talk about ... like Shaila Jiwa try to encourage people to come ... is a condition that can be classified under two ...
Breaking Medicine News(10 mins):Health News:Abington Hospital Selected to Join Baby-Friendly Hospital Initiative 2Health News:Botox, Wrinkles and Double Chins: The Most-Asked Beauty Problems According to Google 2Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Patients of Urinary Incontinence Should Not "Hide And Suffer," States Physiotherapist from Burnaby Physiotherapy Clinic 2
... , CHICAGO, July 16 GoHealthInsurance ... for quality health insurance, through a network of technology-enabled health insurance ... Owens as Senior Vice President. , , ... insurance, health care and financial industries, and has significant expertise in ...
... 16 Immucor, Inc. (Nasdaq: BLUD ), a ... transfusion industry, today announced that Geoffrey S. Crouse has been ... , In this newly created position, ... as well as sales, marketing and customer service. Mr. Crouse ...
... genes alone aren,t destiny, study finds , THURSDAY, July ... problems are influenced by both genetic and environmental factors, ... on genetic and environmental influences on behavior was often ... of psychiatry, psychology, and human and molecular genetics at ...
... , , BATON ROUGE, ... first of four new facilities designed to help the organization boost ... new Red Cross buildings, located in Baton Rouge, LA, Tallahassee, FL, ... by a $25 million gift from the Kuwaiti people through the ...
... Ohio, July 16 Bedford Laboratories(TM), a division of Ben Venue ... USP. This product is AP rated and is equivalent to ... to treat several types of infections caused by susceptible bacteria. , ... http://www.newscom.com/cgi-bin/prnh/20070809/CLTH157LOGO ) , , ...
... spread, CDC says , THURSDAY, July 16 (HealthDay News) ... of infant illness in the United States, could be ... where infections are likely to spread and by the ... A team including scientists from the U.S. Centers for ...
Cached Medicine News:Health News:GoHealthInsurance Announces Appointment of Mike Owens as Senior Vice President 2Health News:Immucor Appoints Chief Operating Officer 2Health News:Teen Behaviors Stem From Genetics, Environment 2Health News:Gulf Coast Residents to Benefit From Gift of Kuwaiti People 2Health News:Bedford Laboratories(TM) to Begin Shipping Ceftriaxone for Injection USP 2Health News:New Insights Could Help Shield Babies From Diarrhea Bug 2
Terumo's Optitorque offers superior torque and precision control. It's patient-friendly, high torque design makes it the catheter of choice for demanding angiography....
Jography angiographic catheter has a new material combination, a patented angled weld, a flat wire braid design with a XXL lumen. It also has an atraumatic soft tip....
Femoral selective catheter. Catheter material used is polyurethane (TRICOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Medicine Products: